|Dr. Michael Jeffrey Sinclair||Exec. Chairman||1.18M||N/A||1943|
|Mr. Nicolas Serandour||CEO & Exec. Director||1.21M||N/A||N/A|
|Prof. Stephen Myers||Exec. Director||416.28k||N/A||1947|
|Mr. Ed Lee||COO & Pres of Europe||N/A||N/A||N/A|
|Mr. Graham Pughe||Sr. Vice-Pres of Accounting & IT||N/A||N/A||N/A|
Advanced Oncotherapy plc, together with its subsidiaries, focuses on providing radiotherapy systems for the treatment of cancer. The company operates through two segments, Proton Therapy and Healthcare Related Properties. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also rents a medical facility. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was incorporated in 2005 and is headquartered in London, the United Kingdom.
Advanced Oncotherapy plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.